↓ Skip to main content

Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study

Overview of attention for article published in Investigational New Drugs, April 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
32 Mendeley